Portfolio company
Leash Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This deep-tech company generates large-scale biochemical datasets and machine learning models to assist biopharmaceutical partners and internal teams in designing new medicinal drugs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
A-Alpha Bio
This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.
DeepMirror
This company develops an artificial intelligence platform for medicinal chemists at biotechnology and pharmaceutical firms to design and optimise drug molecules.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
Insitro
This deep-tech company uses machine learning and genomic data to develop therapeutic drugs for patients with various human diseases.
DeepMirror AI
This company provides a drug design platform that uses machine learning to help medicinal chemists identify and optimise molecules for biopharmaceutical research.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
AI-DRIVEN CHEMISTRY
This company provides a machine learning platform to help pharmaceutical and chemical organisations accelerate research and development by optimizing experiments using small datasets.
